PRKDC and lung carcinoma: We used the ATR inhibitor VE-821 and the DNA-PK inhibitor NU-7441 as inhibitors of HRR and NHEJ, respectively, and analyzed their synthetic lethal effects on FHIT-deficient lung cancer cells.